Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the treatment of glioblastoma. Vortioxetine, an antidepressant, showed promising anti-glioblastoma activity, significantly reducing tumor size in preclinical trials.
Financial Pressures Named Top Barrier to Digital Health Adoption
What You Should Know: Majority 90.5% of College of Healthcare Information Management Executives (CHIME) members have adopted digital health, despite nearly half (47.6%) cited financial
August 8, 2023